Fresenius Medical Care AG KGaA Cash Flow from Investing Activities 2010-2024 | FMS
Fresenius Medical Care AG KGaA annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
- Fresenius Medical Care AG KGaA cash flow from investing activities for the quarter ending June 30, 2024 was $0.274B, a 184.63% decline year-over-year.
- Fresenius Medical Care AG KGaA cash flow from investing activities for the twelve months ending June 30, 2024 was $-0.877B, a 50.91% decline year-over-year.
- Fresenius Medical Care AG KGaA annual cash flow from investing activities for 2023 was $-0.589B, a 23.91% decline from 2022.
- Fresenius Medical Care AG KGaA annual cash flow from investing activities for 2022 was $-0.774B, a 45.3% decline from 2021.
- Fresenius Medical Care AG KGaA annual cash flow from investing activities for 2021 was $-1.415B, a 7.19% decline from 2020.
| Fresenius Medical Care AG KGaA Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $-589 |
| 2022 | $-774 |
| 2021 | $-1,415 |
| 2020 | $-1,525 |
| 2019 | $-3,680 |
| 2018 | $-289 |
| 2017 | $-1,121 |
| 2016 | $-1,379 |
| 2015 | $-1,001 |
| 2014 | $-2,691 |
| 2013 | $-1,206 |
| 2012 | $-2,281 |
| 2011 | $-2,345 |
| 2010 | $-1,125 |
| 2009 | $-698 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.214B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $210.334B | 25.69 |
| Intuitive Surgical (ISRG) | United States | $182.994B | 95.67 |
| Alcon (ALC) | Switzerland | $46.005B | 32.38 |
| Edwards Lifesciences (EW) | United States | $41.343B | 25.70 |
| IQVIA Holdings (IQV) | United States | $39.384B | 22.32 |
| IDEXX Laboratories (IDXX) | United States | $37.127B | 44.66 |
| DexCom (DXCM) | United States | $28.045B | 42.24 |
| STERIS (STE) | Ireland | $22.129B | 25.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.113B | 0.00 |
| Waters (WAT) | United States | $19.387B | 28.90 |
| Hologic (HOLX) | United States | $18.849B | 20.49 |
| Sysmex ADR (SSMXY) | Japan | $11.637B | 36.49 |
| Teleflex (TFX) | United States | $11.083B | 17.23 |
| Globus Medical (GMED) | United States | $10.165B | 28.44 |
| Penumbra (PEN) | United States | $8.207B | 79.43 |
| Glaukos (GKOS) | United States | $7.621B | 0.00 |
| Masimo (MASI) | United States | $7.601B | 40.71 |
| PROCEPT BioRobotics (PRCT) | United States | $4.855B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.358B | 24.70 |
| LivaNova (LIVN) | United Kingdom | $2.788B | 16.09 |
| Inari Medical (NARI) | United States | $2.757B | 0.00 |
| TransMedics (TMDX) | United States | $2.749B | 87.15 |
| Veracyte (VCYT) | United States | $2.688B | 166.67 |
| Nihon Kohden (NHNKY) | Japan | $2.611B | 16.25 |
| Elekta AB (EKTAY) | Sweden | $2.340B | 19.06 |
| Tandem Diabetes Care (TNDM) | United States | $2.118B | 0.00 |
| RxSight (RXST) | United States | $1.894B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.511B | 6.88 |
| Artivion (AORT) | United States | $1.116B | 102.42 |
| Pulse Biosciences (PLSE) | United States | $1.086B | 0.00 |
| OPKO Health (OPK) | United States | $1.060B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.854B | 14.52 |
| Alphatec Holdings (ATEC) | United States | $0.789B | 0.00 |
| IRadimed (IRMD) | United States | $0.671B | 36.26 |
| OrthoPediatrics (KIDS) | United States | $0.654B | 0.00 |
| AxoGen (AXGN) | United States | $0.633B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.624B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.622B | 15.71 |
| Pacific Biosciences Of California (PACB) | United States | $0.589B | 0.00 |
| SiBone (SIBN) | United States | $0.549B | 0.00 |
| Paragon 28 (FNA) | United States | $0.435B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.355B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.350B | 10.69 |
| CVRx (CVRX) | United States | $0.307B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.298B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.290B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.226B | 15.84 |
| Inogen (INGN) | United States | $0.220B | 0.00 |
| NeuroPace (NPCE) | United States | $0.202B | 0.00 |
| Nevro (NVRO) | United States | $0.201B | 0.00 |
| Accuray (ARAY) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.177B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.155B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.121B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.117B | 0.00 |
| 908 Devices (MASS) | United States | $0.113B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 16.46 |
| WORK Medical Technology Group (WOK) | China | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.075B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.067B | 0.00 |
| LENSAR (LNSR) | United States | $0.064B | 0.00 |
| InspireMD (NSPR) | Israel | $0.062B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Envoy Medical (COCH) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.048B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.045B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.037B | 0.00 |
| Neuronetics (STIM) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |